Cargando…
Seroresponse to SARS-CoV-2 Vaccines Among Maintenance Dialysis Patients
Autores principales: | Hsu, Caroline M., Weiner, Daniel E., Aweh, Gideon N., Manley, Harold J., Ladik, Vladimir, Frament, Jill, Miskulin, Dana, Argyropoulos, Christos, Abreo, Kenneth, Chin, Andrew, Gladish, Reginald, Salman, Loay, Johnson, Doug, Lacson, Eduardo K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the National Kidney Foundation, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572553/ https://www.ncbi.nlm.nih.gov/pubmed/34758369 http://dx.doi.org/10.1053/j.ajkd.2021.10.002 |
Ejemplares similares
-
Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse
por: Hsu, Caroline M., et al.
Publicado: (2023) -
Seroresponse to Third Doses of SARS-CoV-2 Vaccine Among Patients Receiving Maintenance Dialysis
por: Hsu, Caroline M., et al.
Publicado: (2022) -
COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider
por: Hsu, Caroline M., et al.
Publicado: (2021) -
SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance Dialysis
por: Manley, Harold J., et al.
Publicado: (2023) -
Influenza Vaccines in Maintenance Hemodialysis Patients: Does Seroresponse Vary With Different Vaccine Formulations?
por: Barbar, Tarek, et al.
Publicado: (2022)